All4NutraNo products in the cart.
All4NutraStartseite » Pellet » Page 16
Although mechanistic numerical simulations can offer great insights into a process, they are limited with respect to resolved process time....
What is the ExciPerience? ExciPerience 2021 was the new virtual event around every aspect of pharmaceutical excipients. ExciPerience covered all...
In this work, sucrose acetate isobutyrate (SAIB) and polylactic co-glycolic acid (PLGA) were used alone or in combination as a...
Continuous production of pharmaceuticals requires traceability from the raw material to the final dosage form. With that regard, understanding the...
SYN-004 (ribaxamase) delayed release drug product is a multi-particulate, hard capsule for oral delivery of a recombinant β-lactamase enzyme designed...
Most of the commercially available pharmaceutical products for oral administration route are marketed in the tablet dosage forms. However, compression...
Purpose Drug X is high solubility, high permeability BCS/DCS I small molecule drug. High dose and potential pediatric indication required...
The objectives of this study are the development and evaluation of modified release multi-particulate drug delivery systems containing a BCS...
Written by Dr Steve Robinson | 01-Dec-2020 Excipients from different batches or vendors may be variable in quality and it...
Objective(s): Liqui-Mass technology has shown promising advantages in terms of commercial production and formulation manipulation. This study attempts to further...
Copyright: PharmaExcipients AG